Financhill
Back

Milestone Pharmaceuticals Vs. Monopar Therapeutics Industry Stock Comparison

Sell
47

MIST
Milestone Pharmaceuticals

Last Price:
$2.19
Seasonality Move:
-19.56%
Buy
72

MNPR
Monopar Therapeutics

Last Price:
$46.13
Seasonality Move:
-10.68%
Sell
47
Milestone Pharmaceuticals (MIST) is a Sell

Is Milestone Pharmaceuticals a Buy, Sell or Hold?

  • The current Milestone Pharmaceuticals [MIST] share price is $2.19. The Score for MIST is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $47.11. The Score for MNPR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MIST Stock Price Chart

What is Milestone Pharmaceuticals's stock price today?

  • The Milestone Pharmaceuticals share price today is $2.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MIST is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $47.11
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing slight selling pressure.

MIST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 61.95 Buy
Chaikin Money Flow: 804129 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.96 - 2.18) Buy
Bollinger Bands (100): (1.52 - 2.02) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.91 Buy
Relative Strength Index (14 RSI): 67.54 Buy
Chaikin Money Flow: -4578 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.48 - 42.44) Buy
Bollinger Bands (100): (7.67 - 31.27) Buy

MIST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.02 Buy
20-day SMA: 2.03 Buy
50-day SMA: 1.97 Buy
200-day SMA: 1.64 Buy
8-day EMA: 2.05 Buy
20-day EMA: 2.03 Buy
50-day EMA: 1.96 Buy
200-day EMA: 1.83 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.31 Buy
20-day SMA: 36.03 Buy
50-day SMA: 28.53 Buy
200-day SMA: 11.37 Buy
8-day EMA: 44.18 Buy
20-day EMA: 38.04 Buy
50-day EMA: 29.95 Buy
200-day EMA: 15.55 Buy

Milestone Pharmaceuticals Earnings Growth & MIST Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.20 per share, and an increase next year of $0.95 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.

Milestone Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):